This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
The below stocks have been identified as having potential to register bigger than normal share price moves (up or down) today based on the news cited
FlyBe opens takeover discussions with Virgin Atlantic.
BP marks first production at Clair Ridge (48.1% interest) in North Sea, it’s sixth new upstream project brought on-line this year, targeting 640m barrels, peak production 120K/day.
Indivior says Health Canada approves SUBLOCADE injection for patients with moderate to severe opioid use disorder.
Fuller, Smith & Turner H1 revenue +6% YoY, pre-tax profit -12%, dividend +3%, net debt +10.7%. Profitability impacted by investment front-loading, but which should deliver good Christmas returns.
Interserve 9-month trading in-line, Fit for growth delivering savings; significant FY margin improvement expected, but net debt now seen £50m/8.6% higher, unwinding in 2019; deleveraging plan to be announced early 2019, options including new capital and more disposals.
Ibstock sells Glen-Grey US brick business for net $95m (8x EBITDA) after strategic review; proceeds to repay debt. UK maintenance program progressing well; Outlook positive despite Brexit uncertainty; Adj. EBITDA still expected £121-125m.
(Sources: Company newswires, Bloomberg, CNBC, FT, Reuters, Wall Street Journal)
For more information on any of these individual news items, call into the trading floor
| Stock | Code | Close | High | Low |
| CENTRICA | CNA | -9.1% | -5.2% | -9.4% |
| SEVERN TRENT | SVT | 0.5% | 2.3% | -2.2% |
| MITCHELLS & BUTLERS | MAB | 2.8% | 4.0% | -0.2% |
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.
Prepared by Michael van Dulken, Head of Research